Some research has suggested that up to 80% of the US health care dollar is driven by diagnostic tests. The world of in vitro diagnostic testing though is often a hidden part of clinical medicine. In this talk, Dr. Larry Kessler from the School of Public Health and Community Medicine at the University of Washington describes the US Food and Drug Administrations approach to classification of in vitro diagnostic devices FDA and their regulatory pathways.
To see more videos from the University of Washington visit uwtv.org.
Link to this comment:
All Comments (0)